Session: 40. Fungal Diagnostics
Background. The T2Candida (T2C) assay is an FDA-approved, non-culturebased rapid diagnostic that utilizes PCR and magnetic resonance technology to detect candidemia in a whole blood specimen. T2C can detect the 5 most common pathogenic species: C. albicans, C. tropicalis, C. parapsilosis, C. krusei, and C. glabrata. The sensitivity of T2C is reported to be 88-94%, varying by the species, based on the original clinical trial from 2015. Only 6 patients with candidemia were included in the study, so it was supplemented with samples spiked with known quantities of Candida spp. In this study, we sought to evaluate the sensitivity of T2C with routine usage in a tertiary-care academic hospital.
Methods. All patients with a blood culture (BC) positive for Candida spp. during the years 2016 through 2018 were identified. Repeat positive cultures of the same species within 30 days of the initial culture were excluded. We then reviewed the medical records of those patients with a T2C collected ±12 hours from the time of the BC collection. Data collection included demographics, time to antifungal therapy, time to culture reported positive, impact of false negative T2C on antifungal therapy, and 30-day mortality.
Results. There were 281 episodes of candidemia (designated as a positive blood culture) in the study period. Forty-four of these episodes had a T2C collected within the specified timeframe ( Figure 1 ). Overall, there were 17 false-negative T2C, reflecting a sensitivity of 61% (27/44). Excluding species not detected by T2C, the sensitivity was 71% (21/38). Of the false-negative group, antifungal therapy was impacted in 8 patients: delayed initiation in 6 patients (1-4 days) and treatment interruption in 2 patients (1 dose each). Demographics, time to treatment, time to culture positivity, and 30-day mortality were similar in the two groups (Table 1) .
Conclusion. In spite of the test being readily available and increasingly used, only 44/281 (16%) of patients with a positive BC had a T2C ordered concurrently. Our experience shows a much lower sensitivity than the clinical trial, in part due to species not detected by T2C. Considering only those organisms on the T2C panel, the false-negative rate was 29%. Impact on treatment was limited to half of the false-negative patients with no difference in mortality.
Background. Invasive aspergillosis is a major cause of infectious morbidity and mortality in immunocompromised patients.However, definitive diagnosis of invasive Aspergillus infection is still difficult due to the lack of a rapid, sensitive and specific diagnostic methods. In this studies, we investigated 2-deoxy-2-[ 18 F]fluorosorbitol ([ 18 F]FDS) which has been reported to be accumulated in Gram-negative bacteria but not in Gram-positive bacteria or healthy mammalian or cancer cells, for the imaging detection of Aspergullus fumigatus infections with PET in vivo.
Methods. [ 18 F]FDS was synthesized by reduction of 2-deoxy-2-[ 18 F]fluoro-dglucose ([ 18 F]FDG) using NaBH 4 . When the reaction was complete, the mixture was adjusted to a pH value to 6.5-7.5. Subsequently, the solution was filtered directly into a sterile product vial through a Sep-Pak Alumina N cartridge with a sterile filter. The probe uptake assay was performed by incubating bacterial cell and fungi with [ 18 F] FDS (20 µCi) at 37°C for 2 h. Female BALB/c were immunosuppressed with cyclophosphamide and cortisone acetate prior to A. fumigatus intranasal, intramuscular, brain infection. The mircoPET images were obtained at 2 h after i.v. injection of [ 18 F] FDS in infected mice.
Results. In vitro uptake test revealed significantly higher accumulation of [ 18 F]FDS at 2 hin A. fumigatus, C. albicans and R. oryzae rather than with bacterial strains (Figure 1 ). PET imaging of BALB/c mice with pulmonary A. fumigatus infections showed obvious accumulation of [ 18 F]FDS in the infected lungs compared with control ( Figure 2 ). [ 18 F]FDS PET imaging also detected A. fumigatus muscle and brain infection in mice. In infected shoulder muscle of mice, [ 18 F] FDS PET imaging showed high legion-to-background ratio at 2 h. (4.05 ± 1.59, Figure 3 ).
Conclusion. [ 18 F]FDS PET study demonstrated stable uptake in infected tissue with A. fumigatus and rapid clearance from the blood and other organs. [ 18 F]FDS could be a useful imaging probe visualizing the invasive aspergillosis in vivo.
